Jacques Bonneterre

发表

Insulin-like growth factor 1 receptors in human breast tumour: localisation and quantification by histo-autoradiographic analysis.

J. Peyrat, J. Djiane, F. Pollner, 1992, British Journal of Cancer.

ERBB2 oncogene in human breast cancer and its clinical significance.

F. Révillion, J. Bonneterre, J. Peyrat, 1998, European journal of cancer.

A phase II study in advanced breast cancer: ZD1694 ('Tomudex') a novel direct and specific thymidylate synthase inhibitor.

M. Namer, J. Bonneterre, J. Zalcberg, 1996, British Journal of Cancer.

Insulin-like growth factor 1 receptors in human breast tumour: localisation and quantification by histo-autoradiographic analysis.

J. Peyrat, M. Vilain, J. Djiane, 1992, British Journal of Cancer.

Plasma c-erbB2 concentrations in relation to chemotherapy in breast cancer patients.

F. Révillion, J. Bonneterre, J. Peyrat, 1996, European journal of cancer.

Analysis of p16 gene deletion and point mutation in breast carcinoma.

B. Quesnel, J. Bonneterre, J. Peyrat, 1995, British Journal of Cancer.

High activity and tolerability demonstrated for exemestane in postmenopausal women with metastatic breast cancer who had previously failed on tamoxifen treatment.

O. Mariani, J. Bonneterre, L. Dirix, 2000, European journal of cancer.

Plasma insulin-like growth factor in primary breast cancer patients treated with adjuvant chemotherapy.

F. Révillion, J. Bonneterre, J. Peyrat, 1998, British Journal of Cancer.

Age as a prognostic factor in breast cancer.

J. Bonneterre, J. Peyrat, L. Vanlemmens, 1998, Anticancer research.

The relationship between concentrations of circulating soluble E-selectin and clinical, pathological, and biological features in patients with breast cancer.

F. Révillion, J. Bonneterre, J. Peyrat, 1998, Clinical cancer research : an official journal of the American Association for Cancer Research.

Prognostic significance of circulating P53 antibodies in patients undergoing surgery for locoregional breast cancer

J. Bonneterre, T. Soussi, R. Lubin, 1995, The Lancet.